history of glp 1 drugs Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Glucagon-like peptide-1 analogs: Miracle drugs
Description
"Lilly lowers the price of Zepbound (tirzepatide) single-dose vials." Press release
They affect 20%30% of patients and usually cease during long-term therapy after a few weeks
A., Burlacu, A
We monitor metabolic parameters
Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme
